chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Influenza like illness
Clinical narrative: diarrhea almost constantly no matter what I eat for almost 2 weeks; mild flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (mild flu symptoms) and DIARRHOEA (diarrhea almost constantly no matter what I eat for almost 2 weeks) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (mild flu symptoms). On 05-Mar-2021, the patient experienced DIARRHOEA (diarrhea almost constantly no matter what I eat for almost 2 weeks). At the time of the report, INFLUENZA LIKE ILLNESS (mild flu symptoms) and DIARRHOEA (diarrhea almost constantly no matter what I eat for almost 2 weeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dysstasia, Myalgia
Clinical narrative: chills and muscle pain; chills and muscle pain; couldn't stand up and it was as if he would "fall into a puddle."; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills and muscle pain), MYALGIA (chills and muscle pain) and DYSSTASIA (couldn't stand up and it was as if he would "fall into a puddle.") in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills and muscle pain), MYALGIA (chills and muscle pain) and DYSSTASIA (couldn't stand up and it was as if he would "fall into a puddle."). At the time of the report, CHILLS (chills and muscle pain), MYALGIA (chills and muscle pain) and DYSSTASIA (couldn't stand up and it was as if he would "fall into a puddle.") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pain, Pain in extremity, Pyrexia
Clinical narrative: Still bothering today; arm started hurting again; Shoulder is hurting/Joint pain; arm very sore; low grade fever (99.9°F); body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm very sore), PYREXIA (low grade fever (99.9°F)), MYALGIA (body aches), PAIN IN EXTREMITY (arm started hurting again) and ARTHRALGIA (Shoulder is hurting/Joint pain) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm very sore), PYREXIA (low grade fever (99.9°F)) and MYALGIA (body aches). On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm started hurting again) and ARTHRALGIA (Shoulder is hurting/Joint pain). On an unknown date, the patient experienced PAIN (Still bothering today). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm very sore), PYREXIA (low grade fever (99.9°F)), MYALGIA (body aches), PAIN IN EXTREMITY (arm started hurting again), ARTHRALGIA (Shoulder is hurting/Joint pain) and PAIN (Still bothering today) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Illness, Pain
Clinical narrative: got sick; felt really bad; headaches; achy; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got sick), FEELING ABNORMAL (felt really bad), HEADACHE (headaches) and PAIN (achy) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (got sick), FEELING ABNORMAL (felt really bad), HEADACHE (headaches) and PAIN (achy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (got sick), FEELING ABNORMAL (felt really bad), HEADACHE (headaches) and PAIN (achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications reported were Unknown medicine for bipolar disorder.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Fatigue, Headache, Vomiting
Clinical narrative: Confusion; Vomiting; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Confusion), VOMITING (Vomiting), HEADACHE (Headache) and FATIGUE (Fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced CONFUSIONAL STATE (Confusion), VOMITING (Vomiting), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, CONFUSIONAL STATE (Confusion), VOMITING (Vomiting), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Treatment medicines were not reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pain, Pyrexia
Clinical narrative: achiness; chills; fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achiness), CHILLS (chills), PYREXIA (fever) and NAUSEA (Nausea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN (achiness), CHILLS (chills), PYREXIA (fever) and NAUSEA (Nausea). At the time of the report, PAIN (achiness), CHILLS (chills), PYREXIA (fever) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Malaise, Nausea, Restlessness
Clinical narrative: Going to the restroom a lot; Nauseated; Shaky; Not feeling too well; Weak; Dizzy spells; A spontaneous report was received from a consumer concerning herself, a 42-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced dizzy spells, felt weak, Fainting (Syncope), not feeling too well, weak, shaky, and nauseated, going to the restroom a lot.  The patient's medical history was not provided by the reporter. Concomitant medications were also not reported.  On 18Mar2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot/Batch number: 032M20A) intramuscularly in her right deltoid for prophylaxis of COVID-19 infection.   On 18Mar2021, the patient experienced dizzy spells, felt weak and almost Fainted. On19 Mar2021, patient was not feeling too well, weak, shaky, and nauseated. On an unknown patient going to the restroom a lot. The event almost Fainted was considered to be medically significant.  Action taken with mRNA-1273 in response to the events was Unknown.   The outcome of the events, dizzy spells, felt weak and almost Fainted, patient was not feeling too well, weak, shaky, and nauseated, going to the restroom a lot was considered to be unknown at the time of this report.; Reporter's Comments: Based on the current available information which shows a strong temporal association between the use of the mRNA-1273 and the reported events, a causal relationship cannot be excluded. Nausea is consistent with the safety profile of the product.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Going to the restroom a lot; Nauseated; Shaky; Not feeling too well; Weak; Dizzy spells; A spontaneous report was received from a consumer concerning herself, a 42-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced dizzy spells, felt weak, Fainting (Syncope), not feeling too well, weak, shaky, and nauseated, going to the restroom a lot.  The patient's medical history was not provided by the reporter. Concomitant medications were also not reported.  On 18Mar2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot/Batch number: 032M20A) intramuscularly in her right deltoid for prophylaxis of COVID-19 infection.   On 18Mar2021, the patient experienced dizzy spells, felt weak and almost Fainted. On19 Mar2021, patient was not feeling too well, weak, shaky, and nauseated. On an unknown patient going to the restroom a lot. The event almost Fainted was considered to be medically significant.  Action taken with mRNA-1273 in response to the events was Unknown.   The outcome of the events, dizzy spells, felt weak and almost Fainted, patient was not feeling too well, weak, shaky, and nauseated, going to the restroom a lot was considered to be unknown at the time of this report.; Reporter's Comments: Based on the current available information which shows a strong temporal association between the use of the mRNA-1273 and the reported events, a causal relationship cannot be excluded. Nausea is consistent with the safety profile of the product.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: Aches/pains; dull headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches/pains) and HEADACHE (dull headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20a) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN (Aches/pains) and HEADACHE (dull headache). At the time of the report, PAIN (Aches/pains) and HEADACHE (dull headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided by the reporter. No treatment  medication was provided by the reporter.   This case was linked to MOD-2021-219851, MOD-2021-219851 (Patient Link).
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache
Clinical narrative: Headache; Sore arm from shoulder to elbow; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Sore arm from shoulder to elbow) and HEADACHE (Headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Patient medication history was not provided by the reporter.     On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced ARTHRALGIA (Sore arm from shoulder to elbow). On 19-Mar-2021, the patient experienced HEADACHE (Headache). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN MIGRAINE) for Headache, at an unspecified dose and frequency. On 19-Mar-2021, ARTHRALGIA (Sore arm from shoulder to elbow) had resolved. At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pain in extremity, Palpitations, Pyrexia
Clinical narrative: Sore arm; Heart racing; Diarrhea; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PALPITATIONS (Heart racing), DIARRHOEA (Diarrhea) and PYREXIA (Fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia (control that with diet).    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), PALPITATIONS (Heart racing), DIARRHOEA (Diarrhea) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Sore arm), PALPITATIONS (Heart racing), DIARRHOEA (Diarrhea) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   ? No treatment information was provided. ?
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse drug reaction, Incorrect route of product administration, Nausea, Pain
Clinical narrative: Quite in pain; Experiencing everything listed on the side effects; Nauseous; Vaccine administered in the shoulder joint, not in the muscle; A spontaneous report was received from a consumer concerning a 67-year-old, male patient who experienced vaccine administered in the shoulder joint, not in the muscle (incorrect route of product administration), nauseous (nausea), quite in pain (pain) and experienced everything listed on the side effects (adverse drug reaction).    The patient's relevant medical history was not provided. Concomitant product use was not provided by the reporter.   On 10-Mar-2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: 044A21A) intramuscularly in his left arm for prophylaxis of COVID-19 infection.   On 10-Mar-2021, the patient experienced incorrect route of product administration (vaccine administered in the shoulder joint, not in the muscle). On 11-Mar-2021, the patient experienced nausea and adverse drug reaction. On an unknown date, the patient experienced pain.   Treatment information was not provided/unknown.   Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the event, incorrect route of product administration was recovered.  The outcome of the events, nausea, pain and adverse drug reaction were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Pyrexia
Clinical narrative: Low fever; Congestion in chest; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low fever) and CHEST DISCOMFORT (Congestion in chest) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced PYREXIA (Low fever) and CHEST DISCOMFORT (Congestion in chest). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (Low fever) had not resolved and CHEST DISCOMFORT (Congestion in chest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was  not provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: Warm to the touch at the site of injection; A rash at the site of injection; Itchy at the site of injection; Red at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE RASH (A rash at the site of injection), VACCINATION SITE PRURITUS (Itchy at the site of injection) and VACCINATION SITE ERYTHEMA (Red at the site of injection) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE RASH (A rash at the site of injection), VACCINATION SITE PRURITUS (Itchy at the site of injection) and VACCINATION SITE ERYTHEMA (Red at the site of injection). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch at the site of injection), VACCINATION SITE RASH (A rash at the site of injection), VACCINATION SITE PRURITUS (Itchy at the site of injection) and VACCINATION SITE ERYTHEMA (Red at the site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment taken.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Patient got sick kind of like the flu; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Patient got sick kind of like the flu) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Patient got sick kind of like the flu). At the time of the report, INFLUENZA LIKE ILLNESS (Patient got sick kind of like the flu) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product were  not provided by the reporter.  Second dose scheduled for 01 Apr 2021.  No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: site where they got the vaccine itched; site where they got the vaccine swelled up; site where they got the vaccine turned red; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (site where they got the vaccine itched), VACCINATION SITE SWELLING (site where they got the vaccine swelled up) and VACCINATION SITE ERYTHEMA (site where they got the vaccine turned red) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A2114) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Stroke and Arthritis.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (site where they got the vaccine itched), VACCINATION SITE SWELLING (site where they got the vaccine swelled up) and VACCINATION SITE ERYTHEMA (site where they got the vaccine turned red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE PRURITUS (site where they got the vaccine itched), VACCINATION SITE SWELLING (site where they got the vaccine swelled up) and VACCINATION SITE ERYTHEMA (site where they got the vaccine turned red) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications include medicines for asthma, blood thinner because had stroke and arthritis.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Injection site welt/raised; Headache; Body aches; Injection site sore to touch; Fever; Injection site red; Chills; Fatigue; Injection site swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (Injection site welt/raised), HEADACHE (Headache), MYALGIA (Body aches), VACCINATION SITE PAIN (Injection site sore to touch) and PYREXIA (Fever) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in July 2020 and Sinusitis on 01-Jan-2013. Concurrent medical conditions included Anxiety, GERD, Cholesterol (High cholesterol), Nausea, Depression (Mild depression), Drug allergy (Patient is allergic toAmoxicillin.) and drug allergy (Patient is allergic to bactrim). Concomitant products included ALPRAZOLAM (XANAX SR) from 01-Jan-2001 to an unknown date for Anxiety, ESCITALOPRAM OXALATE (LEXAPRO) from 01-Jan-2017 to an unknown date for Depression, OMEPRAZOLE from 01-Jan-2001 to an unknown date for GERD, SIMVASTATIN from 01-Jan-2010 to an unknown date for High cholesterol, PROMETHAZINE HYDROCHLORIDE (PHENERGAN [PROMETHAZINE HYDROCHLORIDE]) from 01-Jan-2010 to an unknown date for Nausea.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE URTICARIA (Injection site welt/raised), HEADACHE (Headache), MYALGIA (Body aches), VACCINATION SITE PAIN (Injection site sore to touch), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (Injection site red), CHILLS (Chills), FATIGUE (Fatigue) and VACCINATION SITE SWELLING (Injection site swollen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. On 10-Mar-2021, MYALGIA (Body aches), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) had resolved. On 11-Mar-2021, HEADACHE (Headache) had resolved. On 15-Mar-2021, VACCINATION SITE URTICARIA (Injection site welt/raised), VACCINATION SITE PAIN (Injection site sore to touch), VACCINATION SITE ERYTHEMA (Injection site red) and VACCINATION SITE SWELLING (Injection site swollen) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-052006 (E2B Linked Report). This case was linked to MOD-2021-119592 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Event detail updated, medical history updated, concomitant medication list updated, second dose details updated; Sender's Comments:  MOD-2021-052006:Same reporter/unknown patients (Invalid case)
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site urticaria
Clinical narrative: Injection site welt/raised; Headache; Body aches; Injection site sore to touch; Fever; Injection site red; Chills; Fatigue; Injection site swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (Injection site welt/raised), HEADACHE (Headache), MYALGIA (Body aches), VACCINATION SITE PAIN (Injection site sore to touch) and PYREXIA (Fever) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in July 2020 and Sinusitis on 01-Jan-2013. Concurrent medical conditions included Anxiety, GERD, Cholesterol (High cholesterol), Nausea, Depression (Mild depression), Drug allergy (Patient is allergic toAmoxicillin.) and drug allergy (Patient is allergic to bactrim). Concomitant products included ALPRAZOLAM (XANAX SR) from 01-Jan-2001 to an unknown date for Anxiety, ESCITALOPRAM OXALATE (LEXAPRO) from 01-Jan-2017 to an unknown date for Depression, OMEPRAZOLE from 01-Jan-2001 to an unknown date for GERD, SIMVASTATIN from 01-Jan-2010 to an unknown date for High cholesterol, PROMETHAZINE HYDROCHLORIDE (PHENERGAN [PROMETHAZINE HYDROCHLORIDE]) from 01-Jan-2010 to an unknown date for Nausea.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE URTICARIA (Injection site welt/raised), HEADACHE (Headache), MYALGIA (Body aches), VACCINATION SITE PAIN (Injection site sore to touch), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (Injection site red), CHILLS (Chills), FATIGUE (Fatigue) and VACCINATION SITE SWELLING (Injection site swollen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. On 10-Mar-2021, MYALGIA (Body aches), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) had resolved. On 11-Mar-2021, HEADACHE (Headache) had resolved. On 15-Mar-2021, VACCINATION SITE URTICARIA (Injection site welt/raised), VACCINATION SITE PAIN (Injection site sore to touch), VACCINATION SITE ERYTHEMA (Injection site red) and VACCINATION SITE SWELLING (Injection site swollen) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-052006 (E2B Linked Report). This case was linked to MOD-2021-119592 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Event detail updated, medical history updated, concomitant medication list updated, second dose details updated; Sender's Comments:  MOD-2021-052006:Same reporter/unknown patients (Invalid case)
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Her temperature was 99.7; She felt nauseated; Next day after receiving 2nd dose, patient didn't feel very good on her feet; Her husband had to walk with her so she couldn't fall/She fell once on next day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Next day after receiving 2nd dose, patient didn't feel very good on her feet), FALL (Her husband had to walk with her so she couldn't fall/She fell once on next day), PYREXIA (Her temperature was 99.7) and NAUSEA (She felt nauseated) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to Librium, Lexapro, dilaudid, Levofloxacin, Zofran, Requip, Zyrtec-D and Iodine) and Allergy (Alcoholic beverages). Concomitant products included THYROID (ARMOUR THYROID), VALSARTAN, LORAZEPAM, OMEPRAZOLE, GABAPENTIN, DESVENLAFAXINE, FLUOXETINE, METOPROLOL, PROMETHAZINE, MELATONIN, RISPERIDONE and MIRTAZAPINE for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (Next day after receiving 2nd dose, patient didn't feel very good on her feet) and FALL (Her husband had to walk with her so she couldn't fall/She fell once on next day). On 19-Mar-2021, the patient experienced PYREXIA (Her temperature was 99.7) and NAUSEA (She felt nauseated). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and CALCIUM CHLORIDE, GLUCOSE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM LACTATE (PEDIALYTE [CALCIUM CHLORIDE;GLUCOSE;MAGNESIUM CHLORIDE;POTASSIUM CHLORIDE;SODIUM CHLORIDE;SODIUM LACTATE]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Next day after receiving 2nd dose, patient didn't feel very good on her feet), FALL (Her husband had to walk with her so she couldn't fall/She fell once on next day), PYREXIA (Her temperature was 99.7) and NAUSEA (She felt nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash, Vaccination site swelling
Clinical narrative: injection site itching; injection site rash; swollen at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (injection site itching), INJECTION SITE RASH (injection site rash) and VACCINATION SITE SWELLING (swollen at the injection site) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CARBIDOPA, LEVODOPA (SINEMET), ROSUVASTATIN, PANTOPRAZOLE and DONEPEZIL for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced INJECTION SITE PRURITUS (injection site itching), INJECTION SITE RASH (injection site rash) and VACCINATION SITE SWELLING (swollen at the injection site). At the time of the report, INJECTION SITE PRURITUS (injection site itching), INJECTION SITE RASH (injection site rash) and VACCINATION SITE SWELLING (swollen at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not provided by the reporter.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Erythema, Feeling hot, Headache
Clinical narrative: Dizziness; Hot on her face; Black and blue arm; Rapid pulse; Arm pain; Itchiness on her face; Redness on her face; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), FEELING HOT (Hot on her face), SKIN DISCOLOURATION (Black and blue arm), HEART RATE INCREASED (Rapid pulse) and PAIN IN EXTREMITY (Arm pain) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced DIZZINESS (Dizziness), FEELING HOT (Hot on her face), SKIN DISCOLOURATION (Black and blue arm), HEART RATE INCREASED (Rapid pulse), PAIN IN EXTREMITY (Arm pain), PRURITUS (Itchiness on her face), ERYTHEMA (Redness on her face), HEADACHE (Headache) and CHILLS (Chills). The patient was treated with ACETYLSALICYLIC ACID (ASPIRINE) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), FEELING HOT (Hot on her face), SKIN DISCOLOURATION (Black and blue arm), PAIN IN EXTREMITY (Arm pain), PRURITUS (Itchiness on her face), ERYTHEMA (Redness on her face), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown and HEART RATE INCREASED (Rapid pulse) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported.  Treatment details included Bag of ice.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Pain in extremity, Pruritus, Skin discolouration
Clinical narrative: Dizziness; Hot on her face; Black and blue arm; Rapid pulse; Arm pain; Itchiness on her face; Redness on her face; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), FEELING HOT (Hot on her face), SKIN DISCOLOURATION (Black and blue arm), HEART RATE INCREASED (Rapid pulse) and PAIN IN EXTREMITY (Arm pain) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced DIZZINESS (Dizziness), FEELING HOT (Hot on her face), SKIN DISCOLOURATION (Black and blue arm), HEART RATE INCREASED (Rapid pulse), PAIN IN EXTREMITY (Arm pain), PRURITUS (Itchiness on her face), ERYTHEMA (Redness on her face), HEADACHE (Headache) and CHILLS (Chills). The patient was treated with ACETYLSALICYLIC ACID (ASPIRINE) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), FEELING HOT (Hot on her face), SKIN DISCOLOURATION (Black and blue arm), PAIN IN EXTREMITY (Arm pain), PRURITUS (Itchiness on her face), ERYTHEMA (Redness on her face), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown and HEART RATE INCREASED (Rapid pulse) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported.  Treatment details included Bag of ice.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Ephelides, Rash, Type IV hypersensitivity reaction, Vaccination site rash, Vaccination site swelling
Clinical narrative: "Delayed hypersensitivity reaction"; Very faint pink freckles on top of both feet and on both armpits; Rash on her right hip; Rash at injection site and distal to it; Perimeter was raised; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION ("Delayed hypersensitivity reaction"), EPHELIDES (Very faint pink freckles on top of both feet and on both armpits), RASH (Rash on her right hip), VACCINATION SITE RASH (Rash at injection site and distal to it) and VACCINATION SITE SWELLING (Perimeter was raised) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Dust allergy (dust mites), Allergy to feathers, Ragweed allergy, Pollen allergy (trees), Hypersensitivity and Antifungal treatment. Concomitant products included LEVOTHYROXINE SODIUM (THYROXINE), OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) and DOXYCYCLINE for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at injection site and distal to it) and VACCINATION SITE SWELLING (Perimeter was raised). On 08-Feb-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION ("Delayed hypersensitivity reaction") and EPHELIDES (Very faint pink freckles on top of both feet and on both armpits). 08-Feb-2021, the patient experienced RASH (Rash on her right hip). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, TYPE IV HYPERSENSITIVITY REACTION ("Delayed hypersensitivity reaction"), EPHELIDES (Very faint pink freckles on top of both feet and on both armpits), RASH (Rash on her right hip), VACCINATION SITE RASH (Rash at injection site and distal to it) and VACCINATION SITE SWELLING (Perimeter was raised) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment for the event includes herbal cream called "arnica".   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: significant follow-up appended into AER MOD-2021-051168, Email ID was updated , AE contact information updated, events was updated.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Irritable bowel syndrome, Vaccination complication, Vaccination site erythema, Vaccination site induration, Vaccination site pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of IRRITABLE BOWEL SYNDROME (IBS flare up), VACCINATION COMPLICATION (felt blah), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE INDURATION (hard red lump) and VACCINATION SITE ERYTHEMA (hard red lump) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced IRRITABLE BOWEL SYNDROME (IBS flare up), VACCINATION COMPLICATION (felt blah), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE INDURATION (hard red lump) and VACCINATION SITE ERYTHEMA (hard red lump). On 19-Mar-2021, IRRITABLE BOWEL SYNDROME (IBS flare up), VACCINATION COMPLICATION (felt blah), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE INDURATION (hard red lump) had resolved and VACCINATION SITE ERYTHEMA (hard red lump) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. No treatment information was provided.   Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: A spontaneous report was received from a consumer who was a 64-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced patient did not receive second dose within allowed dosing window/inappropriate schedule of product administration. The patient's medical history was not provided by the reporter. Concomitant medications were not reported. On 26 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number:004M20A) intramuscularly for prophylaxis of COVID-19 infection. As of 11 Mar 2021, the patient stated that he still had not received the second dose of vaccine and was now outside of the recommended dosing window.  Treatment for the events were not reported. Action taken with mRNA-1273 in response to the event was not reported. The event, inappropriate schedule of product administration, was considered recovered/resolved on 26 Jan 2021.; Reporter's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273 (lot #unknown) with no associated AEs reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration
Clinical narrative: knot in her arm around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (knot in her arm around the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A214) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE INDURATION (knot in her arm around the injection site). At the time of the report, VACCINATION SITE INDURATION (knot in her arm around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: NNI- contact info provided
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chest pain, Fatigue, Headache, Malaise
Clinical narrative: feeling sick; had a temperature; headache; fatigue; pain carrying over to her chest; weird pain in her armpit; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (pain carrying over to her chest), AXILLARY PAIN (weird pain in her armpit), MALAISE (feeling sick), PYREXIA (had a temperature) and HEADACHE (headache) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced MALAISE (feeling sick), PYREXIA (had a temperature), HEADACHE (headache) and FATIGUE (fatigue). In March 2021, the patient experienced CHEST PAIN (pain carrying over to her chest) and AXILLARY PAIN (weird pain in her armpit). At the time of the report, CHEST PAIN (pain carrying over to her chest) and AXILLARY PAIN (weird pain in her armpit) outcome was unknown, MALAISE (feeling sick) had resolved and PYREXIA (had a temperature), HEADACHE (headache) and FATIGUE (fatigue) was resolving.            No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: feeling sick; had a temperature; headache; fatigue; pain carrying over to her chest; weird pain in her armpit; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (pain carrying over to her chest), AXILLARY PAIN (weird pain in her armpit), MALAISE (feeling sick), PYREXIA (had a temperature) and HEADACHE (headache) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced MALAISE (feeling sick), PYREXIA (had a temperature), HEADACHE (headache) and FATIGUE (fatigue). In March 2021, the patient experienced CHEST PAIN (pain carrying over to her chest) and AXILLARY PAIN (weird pain in her armpit). At the time of the report, CHEST PAIN (pain carrying over to her chest) and AXILLARY PAIN (weird pain in her armpit) outcome was unknown, MALAISE (feeling sick) had resolved and PYREXIA (had a temperature), HEADACHE (headache) and FATIGUE (fatigue) was resolving.            No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnant patient received 1st dose of Moderna Vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received 1st dose of Moderna Vaccine) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 17-Sep-2020 and the estimated date of delivery was 24-Jun-2021. On 18-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received 1st dose of Moderna Vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-sixth week of the pregnancy.  On 18-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received 1st dose of Moderna Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.